Enovis (ENOV) Total Non-Current Liabilities (2010 - 2026)
Enovis (ENOV) reported Total Non-Current Liabilities of $2.0 billion for Q2 2026, up 3.42% year-over-year from $1.9 billion in Q2 2025, and up 2.12% on a QoQ basis from $1.9 billion in Q4 2025.
Enovis (ENOV) has 17 years of Total Non-Current Liabilities data on file, last reported at $2.0 billion in Q2 2026.
- Quarterly Total Non-Current Liabilities rose 3.42% year-over-year to $2.0 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $2.0 billion (up 3.42% YoY) and the FY2025 annual result came in at $1.9 billion, up 1.45% from the prior year.
- Total Non-Current Liabilities advanced to $2.0 billion in Q2 2026 per ENOV's latest filing, from $1.9 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $3.2 billion in Q2 2022 and bottomed at $656.5 million in Q4 2022.
- The 5-year median for Total Non-Current Liabilities is $1.9 billion (2025), against an average of $1.5 billion.
- The widest annual swing landed in 2022, when Total Non-Current Liabilities plunged 82.41%; it then soared 180.61% in 2024.
- Tracing ENOV's Total Non-Current Liabilities over 5 years: stood at $656.5 million in 2022, then soared by 34.73% to $884.5 million in 2023, then soared by 113.8% to $1.9 billion in 2024, then climbed by 1.45% to $1.9 billion in 2025, then increased by 2.12% to $2.0 billion in 2026.
- Per Business Quant, the three latest ENOV Total Non-Current Liabilities figures stand at $2.0 billion (Q2 2026), $1.9 billion (Q4 2025), and $2.0 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn | 1.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.96 Bn |
| Dec 31, 2025 | 1.92 Bn |
| Oct 3, 2025 | 1.97 Bn |
| Jul 4, 2025 | 1.99 Bn |
| Apr 4, 2025 | 1.89 Bn |
| Dec 31, 2024 | 1.89 Bn |
| Sep 27, 2024 | 1.90 Bn |
| Jun 28, 2024 | 1.90 Bn |
| Mar 29, 2024 | 1.92 Bn |
| Dec 31, 2023 | 884.46 Mn |
| Sep 29, 2023 | 799.46 Mn |
| Jun 30, 2023 | 801.24 Mn |
| Mar 31, 2023 | 683.79 Mn |
| Dec 31, 2022 | 656.46 Mn |
| Sep 30, 2022 | 905.95 Mn |
| Jul 1, 2022 | 868.01 Mn |
| Apr 1, 2022 | 3.24 Bn |
| Dec 31, 2021 | 3.73 Bn |
| Oct 1, 2021 | 2.71 Bn |
| Jul 2, 2021 | 2.61 Bn |
| Apr 2, 2021 | 3.18 Bn |
| Dec 31, 2020 | 3.16 Bn |
| Oct 2, 2020 | 3.11 Bn |
| Jul 3, 2020 | 3.11 Bn |
| Apr 3, 2020 | 3.47 Bn |
| Dec 31, 2019 | 3.28 Bn |
| Sep 27, 2019 | 5.63 Bn |
| Jun 28, 2019 | 5.80 Bn |
| Mar 29, 2019 | 5.76 Bn |
| Dec 31, 2018 | 2.49 Bn |
| Sep 28, 2018 | 2.20 Bn |
| Jun 29, 2018 | 2.14 Bn |
| Dec 31, 2017 | 2.15 Bn |
| Sep 29, 2017 | 2.62 Bn |
| Jun 30, 2017 | 2.47 Bn |
| Mar 31, 2017 | 2.33 Bn |
| Dec 31, 2016 | 2.51 Bn |
| Sep 30, 2016 | 2.45 Bn |
| Jul 1, 2016 | 2.49 Bn |
| Apr 1, 2016 | 2.54 Bn |
| Dec 31, 2015 | 2.53 Bn |
| Sep 25, 2015 | 2.74 Bn |
| Jun 26, 2015 | 2.58 Bn |
| Mar 27, 2015 | 2.68 Bn |
| Dec 31, 2014 | 2.81 Bn |
| Sep 26, 2014 | 2.98 Bn |
| Jun 27, 2014 | 3.23 Bn |
| Mar 28, 2014 | 2.42 Bn |
| Dec 31, 2013 | 2.84 Bn |
| Sep 27, 2013 | 2.71 Bn |
| Jun 28, 2013 | 2.66 Bn |
| Mar 29, 2013 | 2.71 Bn |
| Dec 31, 2012 | 2.88 Bn |
| Sep 28, 2012 | 2.88 Bn |
| Jun 29, 2012 | 2.89 Bn |
| Mar 30, 2012 | 2.90 Bn |
| Dec 31, 2011 | 341.56 Mn |
| Sep 30, 2011 | 776.61 Mn |
| Jul 1, 2011 | 786.79 Mn |
| Dec 31, 2010 | 781.57 Mn |